Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director/PDMR Shareholding

8th Nov 2013 08:56

RNS Number : 5540S
ABCAM Plc
08 November 2013
 



For immediate release

8 November 2013

 

ABCAM PLC

("Abcam" or "the Company")

PDMR dealing

Cambridge, UK: Abcam plc (AIM: ABC), a global leader in the supply of protein research tools, was notified on 7 November 2013 that on 7 November 2013, Ed Ralph, a PDMR of the Company, sold 6,565 ordinary shares of 0.2 pence each in the Company (Ordinary Shares) at a price of 482p per Ordinary Share.

Following these transactions, Dr Ralph's total beneficial interest in the Company is 358,989 Ordinary Shares, representing approximately 0.18 per cent of the current issued share capital of the Company. 

 

For further information please contact:

Abcam

+ 44 (0) 1223 696 000

Jeff Iliffe, Chief Financial Officer

 

Numis Securities - Nominated Adviser & Joint Broker

+ 44 (0) 20 7260 1000

Michael Meade - Nominated Adviser

James Black - Corporate Broking

 

Peel Hunt LLP - Joint Broker

+ 44 (0) 20 7418 8900

Andy Crossley - Corporate Broking

 

Buchanan

+ 44 (0) 20 7466 5000

Mark Court / Fiona Henson / Sophie Cowles

 

Notes for editors:

About Abcam plc

Abcam plc is a leading provider of life science research tools, with a wide range of products and expert technical support, enabling scientists to analyse cells at the molecular level to improve the understanding of health and disease.

Abcam is committed to providing scientists with access to the correct reagents and tools for their research. The Company's catalogue currently comprises more than 124,500 products and is continually evolving to meet customer needs. The range offered includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. Abcam products are supported with detailed, up-to-date and unbiased data on our website.

Headquartered in Cambridge, UK, Abcam has eight global subsidiary offices and ships to over 100 countries. The Company was founded in 1998, and now employs over 700 people. Abcam is quoted on the AIM market of the London Stock Exchange (AIM: ABC).

To find out more, please visit www.abcam.com 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSVVLBBXFFEFBZ

Related Shares:

ABC.L
FTSE 100 Latest
Value8,809.74
Change53.53